Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sachiho Kubo

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Geriatrics & Gerontology International|July 2, 2010
Muscle weakness and neuromuscular junctions in aging and diseaseKazuhiro Shigemoto, Sachiho Kubo, Syuuichi Mori, et al.
Hearing Research|May 11, 2013
RNA analysis of inner ear cells from formalin fixed paraffin embedded (FFPE) archival human temporal bone section using laser microdissection--a technical reportYurika Kimura, Sachiho Kubo, Hiroko Koda, et al.
Cell and Tissue Research|February 17, 2005
Senescence marker protein-30 (SMP30) induces formation of microvilli and bile canaliculi in Hep G2 cellsAkihito Ishigami, Toshiko Fujita, Haruhiko Inoue, et al.
Acta Oto-Laryngologica|September 14, 2007
Quantitative analysis of mRNA in human temporal bonesYurika Kimura, Sachiho Kubo, Hiroko Koda, et al.
Biochemical and Biophysical Research Communications|February 21, 2004
SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life spanAkihito Ishigami, Yoshitaka Kondo, Reiko Nanba, et al.
Pathology International|March 3, 2004
Senescence marker protein-30 knockout mouse as a novel murine model of senile lungTakanori Mori, Akihito Ishigami, Kuniaki Seyama, et al.
Journal of Neuroimmunology|January 7, 2012
Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravisShuuichi Mori, Shigeru Yamada, Sachiho Kubo, et al.
Annals of the New York Academy of Sciences|July 13, 2004
Senescence marker protein-30 knockout mouse as an aging modelNaoki Maruyama, Akihito Ishigami, Masashi Kuramoto, et al.
Journal of Neuroimmunology|March 14, 2012
3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravisShuuichi Mori, Masahiko Kishi, Sachiho Kubo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvyYoshitaka Kondo, Yoko Inai, Yasunori Sato, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Geriatrics & Gerontology International|July 2, 2010
Muscle weakness and neuromuscular junctions in aging and diseaseKazuhiro Shigemoto, Sachiho Kubo, Syuuichi Mori, et al.
Hearing Research|May 11, 2013
RNA analysis of inner ear cells from formalin fixed paraffin embedded (FFPE) archival human temporal bone section using laser microdissection--a technical reportYurika Kimura, Sachiho Kubo, Hiroko Koda, et al.
Cell and Tissue Research|February 17, 2005
Senescence marker protein-30 (SMP30) induces formation of microvilli and bile canaliculi in Hep G2 cellsAkihito Ishigami, Toshiko Fujita, Haruhiko Inoue, et al.
Acta Oto-Laryngologica|September 14, 2007
Quantitative analysis of mRNA in human temporal bonesYurika Kimura, Sachiho Kubo, Hiroko Koda, et al.
Biochemical and Biophysical Research Communications|February 21, 2004
SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life spanAkihito Ishigami, Yoshitaka Kondo, Reiko Nanba, et al.
Pathology International|March 3, 2004
Senescence marker protein-30 knockout mouse as a novel murine model of senile lungTakanori Mori, Akihito Ishigami, Kuniaki Seyama, et al.
Journal of Neuroimmunology|January 7, 2012
Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravisShuuichi Mori, Shigeru Yamada, Sachiho Kubo, et al.
Annals of the New York Academy of Sciences|July 13, 2004
Senescence marker protein-30 knockout mouse as an aging modelNaoki Maruyama, Akihito Ishigami, Masashi Kuramoto, et al.
Journal of Neuroimmunology|March 14, 2012
3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravisShuuichi Mori, Masahiko Kishi, Sachiho Kubo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvyYoshitaka Kondo, Yoko Inai, Yasunori Sato, et al.
Pageof 2